Drug research

IKT-001

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07365332	Inhibikase Therapeutics	Phase 3	Recruiting	2029-06Estimated
Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07632898	Inhibikase Therapeutics	Phase 3	Not yet recruiting	2030-06-30Estimated

Inhibikase TherapeuticsRecruitingPrimary completion: 2029-06 · Estimated

Trial details

Inhibikase TherapeuticsNot yet recruitingPrimary completion: 2030-06-30 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.